SIDA E INFECCIONES VIH

Foto de SIDA E INFECCIONES VIH

Foto de University Hospital of Bern

University Hospital of Bern

Berna, Suiza

Publikationen in Zusammenarbeit mit Forschern von University Hospital of Bern (4)

2019

Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
Antiviral Research, Vol. 170

2017

The not-so-good prognosis of streptococcal periprosthetic joint infection managed by implant retention: The results of a large multicenter study
Clinical Infectious Diseases, Vol. 64, Núm. 12, pp. 1742-1752

2015

Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
PLoS Medicine, Vol. 12, Núm. 3

2014

Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries
AIDS, Vol. 28, Núm. 16, pp. 2461-2473